Form D Explorer

Source evidence

Unravel Biosciences, Inc. · 0001876967-26-000002

D filed Aug. 24, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
MEDFORD
street1
196 BOSTON AVE., SUITE 1000
zipCode
02155
entityName
Unravel Biosciences, Inc.
entityType
Corporation
stateOrCountry
MA
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold4100000number4100000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount4500000number4500000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count2number2/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 82a01df01c96c7f678666609de099c63b617894cd292ec9c3e43d4f6a277ffee. This proves extraction identity, not the accuracy of the filer's claims.